Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins — MP Healthcare Venture Management

Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins

Mari YoshiokaJuly 17, 2024